Ozlem Gungor Tuncer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ozlem Gungor Tuncer has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Reha Tolun
Clinic of Neurology, Memorial Hizmet Hospital, İstanbul, Turkey
3 shared publicationsYakup Krespi
Clinic of Neurology, Şişli Memorial Hospital, İstanbul, Turkey
3 shared publicationsBahar Aksay Koyuncu
Clinic of Neurology, Şişli Memorial Hospital, İstanbul, Turkey
2 shared publicationsEbru Altindag
Department of Neurology, Medical Faculty, Istanbul Bilim University, Istanbul, Turkey
2 shared publicationsEbru Altındağ
2 shared publicationsFeza Deymeer
Department of Neurology Memorial Sisli Hospital Istanbul Turkey
2 shared publications
Latest Publications
- Open Access
- 9 February 2022
- Published by Wiley in Muscle & Nerve
- Vol. 65 (4) , 447-452
Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID‐19
Introduction/Aims: Coronavirus disease‐2019 (COVID‐19) may have a more severe course in patients with myasthenia gravis (MG). We aimed to assess severity of the infection and factors contributing to its severity in a group of MG patients, most of whom were not hospitalized.Methods: One hundred forty outpatients with MG followed between March 2020 and April 2021 were included in our study. Patients were asked to respond to a brief questionnaire in person, by telemedicine, or through electronic messages.Results: Nineteen patients tested positive for COVID‐19 by polymerase chain reaction. Two were asymptomatic. Of the 17 symptomatic patients, 11 had mild symptoms. They either had no treatment or received antivirals, antibiotics, and anticoagulants. Their myasthenia was well‐controlled before infection and was unaffected by COVID‐19. Three patients with moderate COVID‐19 required hospitalization, but not intensive care, and had full recovery. Three other patients, the oldest in the cohort, had severe disease: One patient with a postsurgery myasthenic exacerbation before the infection needed intensive care without intubation, but recovered completely; two morbidly obese patients with comorbidities required intubation and died. Corticosteroids were increased in four of the six moderate/severely affected patients. Immunosuppressive (IS) agents were generally continued. Hydroxychloroquine (HCQ) for COVID‐19 was used in one patient.Discussion: Most patients had mild COVID‐19 and all but two patients recovered. The design of the study made it possible to capture mild cases. Having well‐controlled MG before infection and absence of comorbidities likely affected the course of the infection favorably. IS did not influence the progression.
- 9 February 2022
- Published by Wiley in Muscle & Nerve
- Vol. 65 (4) , 447-452
Open AccessClinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID‐19
Introduction/Aims: Coronavirus disease‐2019 (COVID‐19) may have a more severe course in patients with myasthenia gravis (MG). We aimed to assess severity of the infection and factors contributing to its severity in a group of MG patients, most of whom were not hospitalized.Methods: One hundred forty outpatients with MG followed between March 2020 and April 2021 were included in our study. Patients were asked to respond to a brief questionnaire in person, by telemedicine, or through electronic messages.Results: Nineteen patients tested positive for COVID‐19 by polymerase chain reaction. Two were asymptomatic. Of the 17 symptomatic patients, 11 had mild symptoms. They either had no treatment or received antivirals, antibiotics, and anticoagulants. Their myasthenia was well‐controlled before infection and was unaffected by COVID‐19. Three patients with moderate COVID‐19 required hospitalization, but not intensive care, and had full recovery. Three other patients, the oldest in the cohort, had severe disease: One patient with a postsurgery myasthenic exacerbation before the infection needed intensive care without intubation, but recovered completely; two morbidly obese patients with comorbidities required intubation and died. Corticosteroids were increased in four of the six moderate/severely affected patients. Immunosuppressive (IS) agents were generally continued. Hydroxychloroquine (HCQ) for COVID‐19 was used in one patient.Discussion: Most patients had mild COVID‐19 and all but two patients recovered. The design of the study made it possible to capture mild cases. Having well‐controlled MG before infection and absence of comorbidities likely affected the course of the infection favorably. IS did not influence the progression.
- 11 January 2018
- Published by SAGE Publications in Clinical Eeg and Neuroscience
- Vol. 49 (6) , 425-432
Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria
Objective. We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus (NCSE). Methods. We retrospectively reviewed consecutive patients with unconsciousness followed up in the intensive care unit (ICU). Three clinical neurophysiologists, one of them blinded to clinical and laboratory data, reevaluated all EEG data independently and determined NCSE according to SCC. The incidence of NCSE and ictal EEG patterns and their relationship to clinical, laboratory, neuroradiological, and prognostic findings were assessed. Results. A total of 107 consecutive patients with mean age 68.2 ± 15.3 years (57 females) were enrolled in the study. Primary neuronal injury was detected in 59 patients (55.7%). Thirty-three patients (30.8%) were diagnosed as NCSE. While authors decided to treat 33 patients (30.8%), 32 patients (29.9%) had been treated in real-life evaluation. Clinical and EEG improvement were detected in 12 patients (11.3%) in real-life treatment group showing correlation with lack of intubation and ICU stay related to postsurgical event. Rate of mortality (45.8%) was high showing association with systemic-metabolic etiology, severity of coma and presence of “plus” modifiers in the EEG. Conclusion and Significance. Our findings suggest that SCC is highly compatible with clinical practice in the decision for treatment of patients with NCSE. The presence of “plus” modifiers in the EEG was found to be associated with mortality in these patients and was a significant marker for the high mortality rate.
- 11 January 2018
- Published by SAGE Publications in Clinical Eeg and Neuroscience
- Vol. 49 (6) , 425-432
Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria
Objective. We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus (NCSE). Methods. We retrospectively reviewed consecutive patients with unconsciousness followed up in the intensive care unit (ICU). Three clinical neurophysiologists, one of them blinded to clinical and laboratory data, reevaluated all EEG data independently and determined NCSE according to SCC. The incidence of NCSE and ictal EEG patterns and their relationship to clinical, laboratory, neuroradiological, and prognostic findings were assessed. Results. A total of 107 consecutive patients with mean age 68.2 ± 15.3 years (57 females) were enrolled in the study. Primary neuronal injury was detected in 59 patients (55.7%). Thirty-three patients (30.8%) were diagnosed as NCSE. While authors decided to treat 33 patients (30.8%), 32 patients (29.9%) had been treated in real-life evaluation. Clinical and EEG improvement were detected in 12 patients (11.3%) in real-life treatment group showing correlation with lack of intubation and ICU stay related to postsurgical event. Rate of mortality (45.8%) was high showing association with systemic-metabolic etiology, severity of coma and presence of “plus” modifiers in the EEG. Conclusion and Significance. Our findings suggest that SCC is highly compatible with clinical practice in the decision for treatment of patients with NCSE. The presence of “plus” modifiers in the EEG was found to be associated with mortality in these patients and was a significant marker for the high mortality rate.
- 27 March 2015
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 52 (1) , 59-63
Vascular Ischemia as a Cause of Transient Global Amnesia: A Patient Series
Epileptic, migrainous, and vascular pathologies may cause transient global amnesia (TGA); however, the mechanism of causation remains unclear. We investigated possible vascular causes of TGA. We retrospectively evaluated the clinical and radiologic studies of 13 patients with TGA. On admission, patients underwent diffusion-weighted imaging (DWI) and intra- and extracranial magnetic resonance angiography (MRA); vascular risk factor profiles for diabetes, hypertension, and hyperlipidemia; electroencephalography; and neuropsychological tests. Seven patients underwent control DWIs 24 h after symptom onset. One patient had two punctiform acute infarcts in the left hippocampus, and one had a left pontine paramedian acute infarct. In the second patient, control DWI showed additional left hippocampal and right frontal acute infarcts. None of the patients had electroencephalographic evidence of epileptic activity. All patients except for one had at least one vascular risk factor. The second patient was shown to have paroxsysmal atrial fibrillation during follow-up. Minor posterior circulation ischemic stroke appears to cause TGA in some patients. Evaluations such as DWI and vascular risk factor assessment may be helpful in making the diagnosis.
- 27 March 2015
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 52 (1) , 59-63
Vascular Ischemia as a Cause of Transient Global Amnesia: A Patient Series
Epileptic, migrainous, and vascular pathologies may cause transient global amnesia (TGA); however, the mechanism of causation remains unclear. We investigated possible vascular causes of TGA. We retrospectively evaluated the clinical and radiologic studies of 13 patients with TGA. On admission, patients underwent diffusion-weighted imaging (DWI) and intra- and extracranial magnetic resonance angiography (MRA); vascular risk factor profiles for diabetes, hypertension, and hyperlipidemia; electroencephalography; and neuropsychological tests. Seven patients underwent control DWIs 24 h after symptom onset. One patient had two punctiform acute infarcts in the left hippocampus, and one had a left pontine paramedian acute infarct. In the second patient, control DWI showed additional left hippocampal and right frontal acute infarcts. None of the patients had electroencephalographic evidence of epileptic activity. All patients except for one had at least one vascular risk factor. The second patient was shown to have paroxsysmal atrial fibrillation during follow-up. Minor posterior circulation ischemic stroke appears to cause TGA in some patients. Evaluations such as DWI and vascular risk factor assessment may be helpful in making the diagnosis.
- Open Access
- 1 January 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
Geçici Global Amnezi'ye Neden Olan Vasküler İskemi: Hasta Serisi
- 1 January 2014
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
Open AccessGeçici Global Amnezi'ye Neden Olan Vasküler İskemi: Hasta Serisi
- 1 January 2014
- Published by Elsevier in Neuromuscular Disorders
- Vol. 24 (1) , 36-39
Prepubertal anti-Musk positive myasthenia gravis with long remission
- 1 January 2014
- Published by Elsevier in Neuromuscular Disorders
- Vol. 24 (1) , 36-39
Prepubertal anti-Musk positive myasthenia gravis with long remission
- Open Access
- 15 December 2011
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 48 (4) , 281-284
Tekrarlayan Miller-Fisher Sendromu: Olgu Sunumu
- 15 December 2011
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 48 (4) , 281-284
Open AccessTekrarlayan Miller-Fisher Sendromu: Olgu Sunumu